Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group. (Q39496255)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

Michele Battaglia

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

F Boccardo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

M Pace

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

A Rubagotti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

D Guarneri

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

A Decensi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

F Oneto

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

G Martorana

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

L Giuliani

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

F Selvaggi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

29A

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1088-1093

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Long-term results with a long-acting formulation of D-TRP-6 LH-RH in patients with prostate cancer: an Italian prostatic cancer project (P.O.N.CA.P.) study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A new approach in the hormonal treatment of prostate cancer: complete instead of partial blockade of androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A reexamination of the stable category for evaluating response in patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Total androgen blockade for metastatic cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Total androgen blockade with Zoladex plus flutamide vs. Zoladex alone in advanced prostatic carcinoma: interim report of a multicenter, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Italian Prostatic Cancer Project (PONCAP).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete androgen blockade in prostate cancer. Organizing an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980293-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(05)80293-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8518017%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39496255&oldid=1856201952"